manilatimes15m
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...
Nasal Wash Recalled Due Over Staph Infection Concerns
As flu season trudges on and allergy season approaches, an untimely new recall prompts you to check your frequented medicine cabinet. Ascent Consumer Products Inc. is voluntarily recalling one lot of ...